Phase 1 Safety and Tolerability Study of REGN9533 in Healthy Adults

NCT06665828 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteer

Interventions

DRUG: REGN9533
DRUG: Matching Placebo

Sponsor

Regeneron Pharmaceuticals